Disruption of gap junctional intercellular communication (GJIC) and/or connexins (gap junction proteins) is frequently reported in malignant cell lines and tumours. Certain human papillomaviruses (HPV) associated with the development of cancers, especially of the cervix, have previously been reported to downregulate GJIC in vitro. There is also evidence for reduced gap junctions in cervical dysplasia. However, many squamous hyperproliferative conditions, including HPV-induced warts, often show extensive upregulation of certain connexins. The association between HPV and GJIC, and the mechanism and consequence of deregulated GJIC in cervical tumour progression, remains unclear. Therefore, using a variety of nonmalignant and malignant cell lines and an organotypic raft-culture system, we investigated the relationship between HPV, gap junctions and tumour progression. Established cervical tumour cell lines carrying HPV were unable to communicate via gap junctions (when assayed by dye-transfer techniques). This correlated with lack of connexin protein expression, while transfection with connexins 26 or 43 led to functional gap junction membrane plaques. On the other hand, immortal but nonmalignant cell lines that contained episomal or integrated HPV-16, but required feeder-layer and growth-factor support, were consistently well coupled, and expressed multiple connexins at membrane junctions. In vitro selection of feeder-layer and growth-factorindependent variants eventually lead to loss of GJIC, which correlated with loss of membrane and increased cytoplasmic connexin 43 localization. However, this was preceded by loss of differentiation and stromal invasion, as assayed on the organotypic raft-culture model. Using this model, a comparison between noncoupled, well-coupled and connexin-transfected cell lines revealed no firm correlation between GJIC and dysplasia, but GJIC appeared to favour increased stratification. These findings demonstrate that loss of GJIC is frequent, but appears to occur more as a consequence of, rather than being the cause of, epithelial dysplasia, and may be influenced by, but is not directly attributable to, HPV.
Introduction
Gap junctions, specialised clusters of intercellular channels, allow adjacent cells to directly share ions and hydrophilic molecules of up to B1 kDa in size (Kumar and Gilula, 1996) . This process, known as gap junctional intercellular communication (GJIC) , is thought to control homeostasis and coordination of cellular activities in both excitable and nonexcitable tissues (Simon and Goodenough, 1998) . A single gap junction channel is formed by the docking of two hemichannels from adjacent cells in direct contact with each other. In vertebrates, each hemichannel is thought to comprise a hexamer of four-transmembrane proteins called connexins (Cxs) (Yeager et al., 1998) . In all, 20 human Cx genes have been identified so far, usually classified by their molecular weight, ranging between 25 and 62 kDa in size (Eiberger et al., 2001) . A variety of important functions have now been attributed to these proteins, after analysis of gene knockouts and the discovery of Cx mutations underlying several human diseases and syndromes (Kelsell et al., 2001) .
One of the longstanding interests in the field has been the role of GJIC in carcinogenesis. There is substantial evidence that GJIC and/or Cxs may act as tumour suppressors (reviewed in Trosko and Ruch, 1998) . Reduced or aberrant GJIC or Cx expression has been found in many tumours and tumour cell lines (Holden et al., 1997; Saitoh et al., 1997 Saitoh et al., , 2001 Laird et al., 1999) . Restoration of GJIC in tumour cell lines by Cx transfection can reduce growth and tumourigenicity (Hirschi et al., 1996; Huang et al., 1998; Zhang et al., 1998; Saunders et al., 2001) , and dominant-negative expression of Cxs can reverse this (Duflot-Dancer et al., 1997; Omori and Yamasaki, 1998) . Cx32 null mice have increased incidence of hepatocarcinogenesis (Temme et al., 1997) , whereas fibroblasts derived from Cx43 null mice display increased growth rate, loss of cell adhesion, altered morphology and other properties associated with a transformed phenotype (Martyn et al., 1997) . Other researchers, however, did not observe an obvious increase in the growth rate of fibroblasts derived from Cx43-deficient mice (compared to Cx43 wild-type mice) (Yamakage et al., 1998) . Furthermore, astrocytes from Cx43 null mice have been reported to have reduced growth rate (compared to Cx43 wildtype cells) (Naus et al., 1999) . Recently, identical mutations in Cx26 have been shown to underlie the keratitis-ichthyosis-deafness (KID) (Richard et al., 2002) and hystrix-like ichthyosis-deafness (HID) syndromes (van Geel et al., 2002) , and these patients have an increased incidence of squamous cell carcinoma (SCC). Mutations in Cx43 have also been identified in advanced metastatic lesions of colon tumours (Dubina et al., 2002) .
Although there is strong evidence that GJIC is frequently downregulated in certain cancers, the tumour-suppressive effects appear to be tissue-and Cx-specific (Mesnil et al., 1995; Yano et al., 2001) . Moreover, it seems that the suppressor effect may be due, at least in part, to nongap junctional properties of Cxs (Krutovskikh et al., 2000; Moorby and Patel, 2001; Qin et al., 2002) .
In contrast, it has been observed that GJIC or Cx expression (especially Cx26) is often upregulated in hyperplastic tissues such as psoriatic epidermis and viral warts (Lucke et al., 1999) , benign prostatic hyperplasia (Habermann et al., 2002) and mouse papillomas (Sawey et al., 1996) . Although potent tumour promoters markedly downregulate GJIC in cultured cells (Brissette et al., 1991) , intact skin painted with tumour promoters such as 12-O-tetradecanoylphorbol 13-acetate (TPA) shows a dramatic upregulation of Cx26 and Cx43 expression (Budunova et al., 1995 (Budunova et al., , 1996 Risek et al., 1998) . Another skin tumour promoter, ornithine decarboxylase (ODC), alters Cx43 distribution and increases GJIC in normal and h-Ras-transformed keratinocytes in vitro (Shore et al., 2001) . Transgenic mice expressing dominant-negative Cx32 that abolish GJIC in the liver show delayed liver regeneration after partial hepatectomy, indicating that GJIC might optimize or promote growth under certain conditions .
In more progressed tumour states, induction of Cx expression has been observed in several tumours including breast carcinomas (Jamieson et al., 1998) and ovarian endometrioid adenocarcinomas (Zhai et al., 2002) . Asamoto et al. (1994) proposed that increased expression of Cxs and GJIC is associated with enhanced growth rate in rat bladder carcinogenesis. Cx transfection has also been shown to induce invasive properties of HeLa cells into normal tissue (Graeber and Hulser, 1998) , and expression of Cx26 can increase the metastatic potential of melanoma cells (Ito et al., 2000) . Others have reported GJIC having no obvious influence on tumour behaviour (Lesueur et al., 2002) . Thus, the exact role of connexins and GJIC in different tumours and stages of carcinogenesis is far from elucidated.
In contrast, the oncogenic potential of certain 'highrisk' human papillomaviruses (HPVs), and their causative role in cancer, especially of the cervix and also in other stratifying epithelia, has been long established (zur Hausen, 2002) . Numerous targets and functions of the viral oncoproteins E5 (DiMaio and Mattoon, 2001) , E6 (Mantovani and Banks, 2001 ) and E7 (Munger et al., 2001 ) have been identified, and E6/E7 expression is usually retained and required in cervical cancers. However, cancer arises only in a small subpopulation of HPV-infected individuals; thus, it is thought that several molecular and cellular changes are required over time for malignant conversion to take place.
It was already noted more than four decades ago that normal cervix has abundant gap junctions, and that these are deficient in cervical carcinomas (McNutt and Weinstein, 1969) . Further work also showed that premalignant conditions such as severe dysplasia have a dramatic decreased amount of gap junctions (McNutt et al., 1971) . Immunohistochemistry of cervical biopsies shows reduced Cx43 expression in dysplastic regions compared to normal epithelia (King et al., 2000b) . Work in vitro has suggested that loss of GJIC is an early event in HPV type 16 (HPV-16)-associated cell transformation (Ennaji et al., 1995) . Several studies have demonstrated that the E5 oncoprotein of either bovine or HPV could be responsible for this effect. HPV-16 E5 was shown to downregulate GJIC in a keratinocyte cell line (HaCaT), with evidence indicating that this was due to dephosphorylation of Cx43 (Oelze et al., 1995) . The same group reported an almost complete disappearance of Cx43 when HaCaT cells were grown in an organotypic raft-culture system to induce differentiation, although the mechanism behind this result remains unexplained (Tomakidi et al., 2000) . Primary bovine fibroblasts expressing bovine papillomavirus (type 4) E5 oncoprotein (previously designated E8) also show impaired GJIC (Faccini et al., 1996) . The authors attributed this to E5-binding ductin, the 16 kDa subunit c of the vacuolar H þ -ATPase (V-ATPase) (Goldstein et al., 1991) , which has been suggested to be a major part also of vertebrate gap junctions (Finbow and Pitts, 1993) . However, it was recently shown that binding of BPV-4 E5 to ductin is not sufficient for downregulating GJIC (Ashrafi et al., 2000) .
Our observation that viral warts, in common with other hyperproliferative squamous epithelia, show a dramatic upregulation of Cx26 (Lucke et al., 1999) , prompted us to compare Cx expression and GJIC in HPV-immortalized but nontumourigenic W12 cervical keratinocytes, with that in malignant human cervical keratinocytes expressing high-risk HPV oncoproteins, and then (using a novel in vitro selection procedure combined with organotypic raft cultures), to follow changes in connexins and GJIC during experimental progression of the W12 cells to a dysplastic, invasive phenotype.
Results

HPV-carrying tumour cell lines have no appreciable GJIC
Although many tumour cell lines including HeLa have reduced or no GJIC in vitro (Yamasaki et al., 1999) , we sought to establish whether or not this was characteristic of other HPV-carrying cervical cancer lines. HeLa, an HPV-18-positive cervical adenocarcinoma cell line, is known to be poorly or uncoupled (Mesnil et al., 1995) , and we confirmed this by single-cell microinjection (iontophoresis) of Lucifer Yellow (LY), a negatively charged fluorescent dye of B450 Da in size (Figure 1b) .
In addition, we studied two cervical SCC cell lines, CaSki and SiHa, which harbour integrated HPV-16 genomes and express viral oncoproteins (Friedl et al., 1970; Pattillo et al., 1977) . As with HeLa cells, there was no significant spread of LY to adjacent cells after microinjection (Figure 1c,d) . Occasionally, spread to one or two cells was observed, which could be due to the needle passing through overlapping cell membranes, but LY was never detected in cells of the second order. In contrast, normal primary human epidermal keratinocytes were consistently well coupled, with a typical LY spread of 10-15 cells (Figure 1a) . A HPV-negative cervical tumour cell line, C33a, was also microinjected in order to assay GJIC. This cell line was consistently very well coupled, with visibly faster and larger spread of LY compared to any other cell line (Figure 1g ). Microinjection data correlated with results obtained using the 'scrape loading' with LY (data not shown). Thus, it was shown that GJIC is lost in all the three HPV-expressing cervical carcinoma cell lines, but the HPV-negative tumour cell line is well coupled.
Subclones of a HPV-16-immortalized cell line are well coupled
In order to discern how, when and why GJIC is lost during cancer progression, and whether this is directly attributable to the presence of HPV, we analysed cell lines representing early stages of this process. The W12 cell line was established from a low-grade cervical intraepithelial neoplasia (CIN-1) (Stanley et al., 1989) . W12 cells harbour multiple copies of HPV-16 episomally, are immortal but nonmalignant, and differentiate with a histology similar to CIN-1 when grafted on nude mice (Sterling et al., 1990) . All viral genes are thought to be expressed, including E5 which has been suggested to perturb endocytic trafficking in these cells (Thomsen et al., 2000) . We focused on two established subclones of this cell line, harbouring HPV-16 either episomally (20863 or W12E) or solely integrated (20861 or W12G)  data not shown), collectively named W12E/G herein. The W12G subclone shows a large increase in the levels of E6/E7 transcript and oncoprotein expression compared to W12E (data not shown), as previously described and attributed to increased E6/E7 mRNA stability . Integration is thought to be an important progression step in HPVassociated tumourigenesis, and, indeed, W12G has been shown to have increased growth rate and plating efficiency compared to W12E .
Microinjection of LY in W12E and W12G cells demonstrated that both subclones were consistently well coupled (average spread of B24 cells), and that there was no significant difference between the two lines ( Figure 1e ,f,h).
GJIC correlates with connexin expression
Both W12 sub-clones were well coupled, and typical gap junction plaques could be identified by freeze fracture EM (data not shown). Thus, we compared the Cx profile of normal human keratinocytes (NHKs), W12E, W12G, and the tumour cell lines HeLa, CaSki, SiHa and C33a.
Cx43 is expressed in many epithelial cells. Western blotting with a polyclonal Cx43 antibody demonstrated that this Cx is expressed equally well in W12E and W12G, with no apparent difference in phosphorylated species Figure 2 ). It should be noted that W12E/G cells showed significantly higher levels of Cx43 protein compared to NHKs. Cx43 was not detectable in SiHa and HeLa cells, present at extremely low levels in CaSki cells, but at very high levels in C33a cells (Figure 2 ). These data correlated well with immunofluorescence staining. However, relatively high levels of cytoplasmic Cx43 were noted in W12E and W12G (Figure 3a,b) .
In viral warts, there is a dramatic upregulation of Cx26 (Lucke et al., 1999) . Immunofluorescence using monoclonal antibodies against Cx26 demonstrated a strong, although patchy, expression in W12E/G cells (Figure 3c,d ). Cx26 was not expressed in the tumour cell lines and only at very low levels in NHKs, as seen normally in the epidermis (data not shown). Cx30 was also expressed in a similar patchy pattern in W12E/G cells (Figure 3g ), and tended to colocalize with Cx26. A few Cx40 gap junction plaques were also detected in a subset of W12E/G cells, but Cx30.3, Cx31, Cx31.1 or Cx32 were not detected with our current antibodies (data not shown). As W12G was used for further in vitro tumourigenesis studies, we investigated Cx expression when W12G was grown on an organotypic raft model to induce stratification and differentiation (for histology see Figure 6a ). As seen in Figure 3e -g, Cx43 was detected in all cells except those in the most differentiated layer, whereas Cx26 and Cx30 distribution was more inconsistent and patchy, as observed under monolayer conditions. Connexins localized to typical junction plaques were also seen in cells invading the collagen gel.
It thus appears that the presence of HPV-16, in either episomal or integrated form, with low or high oncoprotein expression, or the presence or absence of the E5 protein, does not downregulate GJIC. On the contrary, there is upregulation of Cx26, Cx30 and Cx43 and extensive GJIC in nonmalignant HPV-associated cell lines.
Transfection with green fluorescent protein-tagged Cx26 or Cx43 forms gap junction membrane plaques, and is sufficient to restore GJIC in tumour cell lines Numerous studies have shown that transfection of HeLa cells with Cxs will re-establish GJIC (Mesnil et al., 1995) . In addition to HeLa cells, we transfected CaSki or SiHa cells with Cx26 or Cx43 tagged to green fluorescent protein (GFP), leading to the formation Figure 5b ). However, a small subset of cells continued to grow, and some of these survived serial passage at 1 : 1, growing relatively well after six passages (Figure 5c ). In order to assay for neoplastic progression, this feeder-layer independent subclone (named GPX) was Gap junctions and HPV-associated tumour biology T Aasen et al grown on the organotypic raft system, and compared to the original W12G and the tumour cell lines. As seen in Figure 6 , all of the cell lines formed stratified tissues in this system, with architecture ranging from nearly normal cervical epithelium (W12, Figure 6a ,b) to almost complete lack of differentiation (CaSki, SiHa, HeLa, Figure 6e ,f,h). A dramatic difference was seen between W12G and GPX, the latter showing almost complete loss of differentiation, coupled with dysplasia and extensive invasion into the collagen gel, a histology more similar to the tumour cell lines (Figure 6c ). However, there was little change seen in GPX coupling by LY microinjection (Figure 7a) .
As with W12E/G, GPX was maintained in a 3 : 1 Dulbecco's modified eagle medium (DMEM) : F12 mixture (10% foetal calf serum (FCS)) supplemented with cholera toxin, hydrocortisone, EGF, transferrin, insulin, adenine and T3. In order to select for cells with a more transformed phenotype, we switched to a simple unsupplemented MEM medium with 10% FCS, which resulted in a similar crisis as observed when removing the feeder layer. Again, there was outgrowth of clones that grew well after about five 1 : 1 passages. These cells (designated GPXY) grow very well (even in reduced FCS), and show increasing spindle cell morphology upon serial passaging. A gradual decrease in LY transfer after serial passaging was observed, with very low levels of communication at passage 40 (Figure 7b ). This correlated with strong cytoplasmic staining of Cx43 and the absence of any typical Cx43 gap junction plaques Correlation between organotypic raft culture and tumourigenicity in vivo GPXY cells, like GPX cells, appear very dysplastic and invasive when grown on the organotypic model ( Figure 6d ). In order to correlate organotypic raft histology to actual phenotype and tumourigenicity in vivo, W12G, GPXY, CaSki and C33a cells were injected subcutaneously into the flank of nude mice. After only 20 days, 8/9 GPXY-injected mice and 5/9 W12G-injected mice had developed tumours, some of which reached 1 cm in diameter. Haematoxylin and eosin (H&E) staining revealed that W12G cells had formed differentiating cysts, with histology similar to rafted cells (Figure 8a,b) . The larger cysts were filled with keratin. GPXY cells, however, formed well-differentiated carcinomas with extensive proliferation and stromal invasion (Figure 8c,d) . After 50 days, 3/6 C33a-injected mice had formed tumours (one large and two small, poorly differentiated carcinomas, Figure 8e) , and 6/6 CaSki cells had formed small tumours (differentiating carcinomas, Figure 8f ). Thus, tumour formation appeared to correlate well with histology of cells grown on the organotypic model.
The role of GJIC in dysplasia, growth and tumourigenesis
Although transfection of tumour cell lines with Cx often reduces growth in vitro and in vivo, there is limited information on how GJIC actually influences cellular behaviour. The fact that Cxs and GJIC are often upregulated in hyperproliferative tissues such as the epidermis (Lucke et al., 1999) , led us to investigate what effect GJIC may have on growth in an environment that mimics a hyperproliferative thickened epithelium. We therefore studied cellular behaviour using the organotypic raft model. As described above, well-coupled GPX cells did not differentiate, and were very invasive (Figure 6c ). Although the very well-coupled C33a tumour cells did not show any signs of differentiation or invasion, they stratified more than any other cell line tested (Figure 6g ). To further explore the possible association between GJIC and tissue architecture and growth, we utilized noncoupled HeLa cells and 
GJIC-proficient HeLa cells stably transfected with Cx43
(HeLa-Cx43), previously established and characterized (Mesnil et al., 1995) . Western blotting confirmed the presence of Cx43 in HeLa-Cx43 (but not in HeLa) (Figure 2 ). Immunofluorescence showed that Cx43 localized to the membrane, and this correlated with functional GJIC upon LY microinjection (data not shown). Under our monolayer growth conditions, HeLa-Cx43 cells showed some reduction in growth rate compared to untransfected HeLa cells; this became increasingly apparent at high cell densities (and thus cell-cell interactions) (Figure 9) . A highly significant difference in saturation density was seen with a mean saturation density of 2.5 Â 10 6 HeLa43 cells/ 60 mm dish compared to 6.7 Â 10 6 HeLa cells/60 mm dish. This correlates with studies on HeLa clones which express Cx43 endogenously (King et al., 2000a) . However, when the cells were grown on the organotypic raft system at the air-liquid interface (to mimic a thickened epithelium with nutrient supply from below), no consistent difference was seen and, in some cases, HeLa-Cx43 cells (Figure 6i ) formed an even thicker epithelium than the untransfected HeLa cells (Figure 6h ). Both HeLa clones showed some limited invasion into the collagen gel. Thus, it appears that GJIC or certain Cxs may enhance or suppress growth depending on the cellular environment, while dysplasia and invasiveness can be relatively independent of these factors. Gap junctions and HPV-associated tumour biology T Aasen et al one of these episomal copies into the host genome. Usually, this results in repression of expression of all virus proteins except for the viral oncoproteins E6 and E7 that become overexpressed, leading (among other changes) to uncontrolled cell cycle progression and inhibition of cell differentiation and apoptosis (zur Hausen, 2002) . Here, we have presented evidence that keratinocytes harbouring high-risk HPV-16 in both the episomal and integrated forms are equally well coupled to each other via gap junctions both in monolayer and organotypic raft culture. Of our two novel progressed cell lines established from W12G cells, only the feederlayer and mitogen-independent line GPXY showed a decrease in cell-cell coupling. This is despite the ability of the presumably less-progressed GPX line to invade in the organotypic raft-culture model, and the complete loss of differentiation in this line. Increased loss of GJIC with increasing passage number was observed for the GPXY line, and it has been shown that several clones from the original HeLa cell line (CCL-2) exhibit high levels of endogenous Cx43 (King et al., 2000a) . Due to the multiple Cxs expressed, loss of GJIC is probably a gradual event, as observed in our in vitro progression model of W12G cells. Our data indicate that the downregulation of GJIC frequently observed in tumours and malignant cell lines is not regulated directly by HPV expression. Our findings contrast with previous reports which indicated that loss of GJIC is an early event in tumourigenesis, and a direct consequence of HPV gene expression (Ennaji et al., 1995; Oelze et al., 1995; Faccini et al., 1996; Tomakidi et al., 2000) . In these reports, either HPV E5 oncoprotein was overexpressed in HaCaT cells (Oelze et al., 1995; Tomakidi et al., 2000) or BPV E5 oncoprotein was overexpressed in fibroblasts (Faccini et al., 1996) , where Cx43 is thought to be the major and possibly only gap junction protein expressed (Fitzgerald et al., 1994) . It was proposed that the E5 oncoprotein might compromise GJIC either by dephosphorylation of Cx43 (Oelze et al., 1995) , or by some interaction with the V-ATPase subunit C (ductin) affecting Cx43 indirectly (Saito et al., 1998) . However, such levels of E5 expression are unlikely to occur in a normal infection (SV Graham, unpublished observation), and E5 expression is often extinguished upon virus genome integration (zur Hausen, 2002) .
It may appear that our findings conflict with evidence that numbers of gap junctions in suprabasal cervical epithelium are decreased at an early stage of dysplasia, possibly to the low numbers normally seen in the basal layer (McNutt et al., 1971; King et al., 2000b) . However, this could simply reflect a failure of the increased connexin expression normally associated with differentiation, the small numbers of junctions remaining being sufficient for metabolic cooperation. At the early stages of dysplasia, cervical epithelium is not markedly thickened, and lesions may remain unchanged or regress after many years. Although HPV infection does not seem to target GJIC directly, the growth-promoting and survival signals such as resistance to apoptosis created by the viral oncoproteins could relieve some of the requirements for GJIC. This may eventually favour the emergence of truly uncoupled clones, as suggested by the results of our in vitro selection experiments.
Our results add to the many observations that loss of GJIC occurs frequently in malignant cell lines and tumours. However, it appears that loss of GJIC does not appear to be a prerequisite for loss of differentiation and keratinocyte morphology. Why then is GJIC impaired completely in many tumourigenic cell lines? It may be that GJIC inhibits cancer cells from detaching, invading, migrating, reattaching or growing in other tissues in the body. Thus, loss of GJIC could be a trade-off that would benefit cells at a certain stage of the carcinogenic process, depending on cell type and origin. For example, single tumour cells may need to transiently lose their gap junctions in order to detach from the main tumour and metastasize. However, gap junctions may again be beneficial (to obtain nutrients, etc) when cancer cells attach to cells of distant tissues forming a microtumour, perhaps particularly before tumour angiogenesis has developed. Our studies indicate only a weak association between GJIC and invasive potential, however, as the well-coupled W12GPX cells displayed invasiveness in raft culture. The role of gap junctions under all these different circumstances is complicated and still poorly documented.
Although GJIC appears to be inhibited in tumour cells, Cxs are clearly upregulated in hyperproliferative, stratified epithelia such as benign warts (Lucke et al., 1999) . Our results, where cells are grown in a model system that mimics the behaviour of hyperproliferative epithelia seen in vivo, suggest that functional GJIC influences growth differentially, depending on the cellular context. In particular, the growth-suppressive effect of Cx43 in HeLa cells seen in the monolayer is diminished when nutrients are supplied from below (i.e. at an air-liquid interface). In this regard, it is interesting that hair follicle keratinocytes cultured from patients with the common 35delG hearing-loss mutation, which essentially leads to Cx26 knockout, show a reduced stratification in an organotypic culture, possibly due to a lower proliferation and migration capacity of the keratinocytes (Wiszniewski et al., 2001) . This raises fundamental questions concerning the general conception that Cxs act as tumour suppressors. By analogy with transforming growth-factor beta 1 (Akhurst and Derynck, 2001) , it is tempting to speculate that Cxs may also operate as 'double-edged swords', promoting or repressing growth depending on the cellular or carcinogenic state. Papillomas, other hyperproliferative epithelia such as psoriatic and tape-stripped skin, or skin painted with tumour promoters, share certain common features: they have greatly elevated Cx expression, are fast cycling, but have usually not undergone extensive molecular and cellular modifications that would allow them to grow under extreme hypoxic or low nutrient conditions. Increased GJIC may therefore facilitate survival of these cells by allowing an increased flow of small molecules and nutrients over a greater distance. This may be particularly important in nonvascular squamous epithelia and microtumours. Interestingly, Cx43 heterozygous mice actually display a decrease in the number of papillomas formed after TPA painting alone (Yamakage et al., 2000) . It is also clear that noncancerous cells constantly require cell survival signals from other cells in order to stay alive. It is possible that some of these signals are transmitted via gap junctions. Additionally, there is evidence that Cx43 hemichannels can act as cell survival signal transducers (Plotkin et al., 2001) . More recently, Cx32, Cx40 and Cx43 have been shown to have strong GJIC-independent antiapoptotic properties in astrocytes, promoting survival against multiple forms of cellular injuries such as oxidative stress (Lin et al., 2003) .
Our studies indicate that the mechanism behind the loss of GJIC is probably multifactorial. Lack of Cx protein expression in our experiments in HeLa, CaSki and SiHa cells correlated with loss of mRNA, as determined by RT-PCR (data not shown), indicating transcriptional downregulation. Gene silencing by methylation has previously been described with Cx26 (Tan et al., 2002) , Cx32 and Cx43 (Piechocki et al., 1999) , and indeed specifically for Cx43 in HeLa cells (King et al., 2000a) . As an alternative, possibly transient mechanism, loss of GJIC during in vitro progression of W12G appeared to be due to a failure of Cx43 to target to the membrane. It is unclear whether the change in phosphorylation status seen by Western blotting is a cause or a result of the cytoplasmic Cx43 accumulation. There is evidence from mouse papilloma cells that Ecadherin junction formation is required to transport Cxs from the cytoplasm to cell-cell contact membranes . Altered E-cadherin expression has been reported in cervical dysplasia and cancer (Vessey et al., 1995) . However, both W12G and GPXY display large amounts of E-cadherin in the membrane (data not shown). In addition, the C33a cell line is E-cadherin negative (our unpublished data; Vessey et al., 1995) ; yet it is very well coupled, and consistently displays large Cx43 membrane plaques. The role of other proteins and cadherins in Cxs trafficking should be clarified by further research. In general, however, loss of GJIC does not appear to be a direct consequence of changes in cell-cell adhesion, since reexpression of Cxs by transfection is often sufficient to restore GJIC. It is also unclear why only Cx43 (and not Cx26 and Cx30) failed to target to the membrane in GPXY cells. Cytoplasmic targeting has been shown to occur after spontaneous mutation of Cx43 in metastatic colon cancers (Dubina et al., 2002) . However, transfection of wild-type Cx43-GFP also targeted to the cytoplasm, although it is possible that mutated endogenous Cx43 acted dominantly on the transfected Cx43-GFP. This Cx-specific cytoplasmic accumulation could be due to the phosphorylation propensity of Cx43 (Lampe and Lau, 2000) , or a difference in proteintrafficking pathways of individual Cxs (Martin et al., 2001) . Despite the presence of Cx26 and Cx30 plaques, very little LY dye transfer was observed. It has been shown, however, that mouse Cx30 channels in transfected HeLa cells cannot transfer LY, but do transfer the smaller dye neurobiotin (Manthey et al., 2001) .
Moreover, this channel restriction may occur in mixed Cx26/Cx30 channels. Thus, it is quite possible that GPXY cells can transfer smaller dyes such as neurobiotin, but not LY. However, the significance of such selective permeability remains unclear.
Further work is clearly needed (both in vitro and in vivo) to clarify the exact role of individual Cxs in specific tissues and under various carcinogenic conditions.
Materials and methods
Cells and culture conditions
Unless otherwise stated, all cells except primary keratinocytes and W12E/G were cultured in Eagle's minimal essential medium (MEM) supplemented with 10% FCS under 5% CO 2 /95% air at 371C. Primary cells were isolated from consented punch biopsies and juvenile foreskins from routine circumcisions, and were cultured in serum-free keratinocyte growth medium (KGM), Clonetics. W12-derived cell lines were cultured in either KGM or a 3T3-J2 feeder-layer system using RM þ medium consisting of a 3 : 1 mixture of DMEM and Ham's F12 medium containing 10% FCS, 0.1 nm cholera toxin, 0.4 mg/ml hydrocortisone, 5 mg/ml insulin, 1.8 Â 10 À4 m adenine, 10 ng/ml EGF, 5 mg/ml transferrin and 2 Â 10 À11 m 3-3-5-triiodo-l-thyronine.
Growth assay in vitro
HeLa or HeLa43 cells (4 Â 10 5 ) were seeded in 60-mm culture dishes and maintained in RM þ medium without antibiotics selection. Cells from three dishes were independently trypsinized and counted (Coulter counter) at selected intervals.
Organotypic cell culture
Cells were seeded on a contracted collagen lattice containing B5 Â 10 6 /ml primary human fibroblasts, as previously described (Bhattacharyya et al., 1998) . RM þ medium (see above) was used for all cell lines, and the lattice was lifted to the air-liquid interface after 2 days and fixed in 4% (v/v) formaldehyde after 12-14 days of stratification. Paraffinembedded tissue models were subjected to standard H&E staining.
Tumourigenicity in mice
Cells (4 Â 10 6 ) in 100 ml Dulbecco's PBS (W12G cells passage 22, GPXY cells passage 57, CaSki cells and C33a cells) were injected subcutaneously into the flank of nude Balb/c mice and monitored weekly. Tumours were excised and subjected to standard H&E.
Microinjection
4% LY-CH in water was microinjected by iontophoresis using 0.5-s pulses of 10 nA at 10 Hz for 2 min. After a further 1 min, the extent of cell coupling was measured by counting the number of cells that had clearly taken up LY.
Antibodies
Polyclonal anti-Cx43 antibody, raised in rabbit against a synthetic peptide corresponding to residues 363-382 of native Cx43, was kindly provided by Dr E Rivedal, Oslo. Monoclonal Cx26 antibodies (13-8100 and 33-5800) and polyclonal Cx30 antibody (71-2200) were purchased from Zymed laboratories Inc.
Plasmids and DNA transfections
Wild-type mouse Cx26 was cloned via Bluescript into pEGFP-N1 (Invitrogen). The stop codon of Cx26 was deleted using site-directed mutagenesis, creating a Cx26-GFP fusion with a 7-amino-acid linker. The Cx26 sequence was verified by sequencing. Cx43-GFP was kindly gifted by Dale Laird, Canada. Cells were grown on glass coverslips and transfected using Lipofectamine 2000 (Invitrogen, Paisley, UK), following the manufacturer's instructions. At 18-48 h post-transfection, the cells were washed twice in PBS, fixed in ice-cold methanol and mounted with Vectashield mounting medium containing propidium iodide (Vector laboratories).
Immunofluorescence microscopy
Cell were grown on sterile 22 Â 22 mm coverslips until 70-90% confluent, washed twice with PBS and fixed with ice-cold methanol for 10 min at À201C. After two washes with PBS, the coverslips were incubated with PBS containing 20% NGS and/ or 20% NHS for 10 min at room temperature. Cells were incubated with primary antibodies diluted in PBS for 1 h at room temperature. Coverslips were washed in PBS before incubation for 1 h with secondary antibodies tagged to fluorescein or Texas-Red diluted 1 : 80 in PBS (Vector laboratories). After washing in PBS, the coverslips were mounted with Vectashield mounting medium (with or without propidium iodine). For immunofluorescence of paraffinembedded sections, alcohol-rehydrated sections were put into a pressure cooker containing preheated citrate buffer, and microwaved for 10 min. The same procedure was employed as above with the following exceptions: All antibodies were diluted in PBS containing 1% bovine serum albumin, 0.1% Tween-20 and 0.01% SDS, and incubated overnight at 41C. For Cx26, the Zymed antibody clone 13-8100 did not work on paraffin-embedded sections, and only clone 33-5800 was used. Images were taken using either a Zeiss LSM510 confocal microscope or a Zeiss Axioplan 2 immunofluorescence microscope.
Western blotting
Protein lysis buffer contained 10 mm Tris pH 7.4, 1% SDS, 1.0 mm sodium orthovanadate and 15% (v/v) fresh protein inhibitor cocktail (Roche, UK). The lysate was mixed 1 : 1 with protein-loading buffer (125 mm Tris (pH 6.8), 4% SDS, 20% glycerol, 10% b-mercaptoethanol and 0.006% bromophenol blue); 50 mg protein was resolved by polyacrylamide gel electrophoresis and subsequently transferred to nitrocellulose membrane. Blots were stained briefly in Ponceau S (Sigma) to verify equal loading. The membrane was preincubated for 1 h at room temperature with 5% dried milk in PBS-0.1%Tween, before overnight incubation at À41C with polyclonal Cx43 antibody diluted 1 : 1000 in PBS-Tween/1% dried milk. Horseradish peroxidase (HRP)-conjugated secondary antibodies were diluted 1 : 1000 in PBS-Tween and incubated for 1 h. The blot was developed using Amersham enhanced chemiluminescence (ECL) kit and Kodak X-OMAT film.
